NKGen Biotech Announces Poster Presentation at the 16th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference -October 19, 2023 at 08:01 am EDT

SANTA ANA, Calif., Oct. 19, 2023 -- NKGen Biotech Inc. , a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK...

Related Keywords

United States ,California ,Boston ,Massachusetts ,Thank Lee ,Blanca Isaura Acosta Gallo ,Kevin Gardner ,Clemente Humberto Zuniga Gil ,Sean Hong ,Denise Chua ,Rufino Menchaca Diaz ,Chris Calabrese ,Pauly Chang ,Katia Betito ,Lucia Hui ,Cesar Alejandro Amescua ,Juan Mata ,Exchange Commission ,Nkgen Biotech Inc ,Corporate Communications ,Nasdaq ,Lifesci Advisors ,Globenewswire Inc ,Clinical Trials ,Disease Annual Meeting ,With Enhanced Activity ,Final Report ,Phasei Dose Escalation ,Humberto Zuniga Gil ,Isaura Acosta Gallo ,Menchaca Diaz ,Alejandro Amescua ,Session Time ,Looking Statements ,Private Securities Litigation Reform Act ,Investor Relations ,Sci Advisors ,Markets ,